The move comes about a month after the drugmaker was criticized for raising the price of its brand-name naloxone injector from $575 to $4,100 over four years, in today's bite-sized hospital and health industry news from Arkansas, Illinois, and Washington.
Business, governments, and other institutions—including hospitals—across the United States and Canada on Thursday responded to bomb threats demanding a ransom in Bitcoin, though law enforcement officials have since said the threats are "NOT considered credible."
Between stuffing, gingerbread cookies, and pumpkin pie, it's no wonder adults gain up to two pounds over the holidays—but a study published this week in BMJ reveals that the annual holiday weight gain doesn't have to be inevitable.
With new financial, clinical, and operational pressures emerging all the time, hospital leaders have a lot to keep up with. When they have a question, they often reach out to our Expert Center for help. Here are two of the most common questions they've asked this month.
Hedda Martin, a 60-year-old Michigan resident who needs a heart transplant, was told to raise $10,000 to cover the cost of immunosuppressive drugs—and while experts say nearly every U.S. medical center has a similar policy, her viral social media post has brought new attention to how costs can create barriers for transplant recipients.